Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SNSS

Sunesis Pharmaceuticals (SNSS) Stock Price, News & Analysis

Sunesis Pharmaceuticals logo

About Sunesis Pharmaceuticals Stock (NASDAQ:SNSS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$2.38
$5.32
52-Week Range
N/A
Volume
1.20 million shs
Average Volume
4.33 million shs
Market Capitalization
$96.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SNSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sunesis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SNSS Stock News Headlines

Peter J Barris's Net Worth
AQSZF Aequus Pharmaceuticals Inc.
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
4 Breakout Stocks to Watch Going Into Labor Day
4 Stocks Under $10 to Trade Now
See More Headlines

SNSS Stock Analysis - Frequently Asked Questions

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) posted its quarterly earnings results on Sunday, November, 15th. The biopharmaceutical company reported ($0.29) earnings per share for the quarter, beating analysts' consensus estimates of ($0.30) by $0.01.

Shares of Sunesis Pharmaceuticals reverse split on Thursday, September 3rd 2020.The 1-10 reverse split was announced on Wednesday, September 2nd 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 2nd 2020. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sunesis Pharmaceuticals investors own include SELLAS Life Sciences Group (SLS), Novavax (NVAX), NVIDIA (NVDA), QUALCOMM (QCOM), OPKO Health (OPK), TherapeuticsMD (TXMD) and VBI Vaccines (VBIV).

Company Calendar

Last Earnings
11/15/2020
Today
7/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:SNSS
Fax
N/A
Employees
24
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$23.33 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.07 million
Price / Cash Flow
N/A
Book Value
$1.42 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$96.26 million
Optionable
Optionable
Beta
2.27
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:SNSS) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners